Literature DB >> 28736648

The utility of positron emission tomography/computed tomography in target delineation for stereotactic body radiotherapy for liver metastasis from primary gastric cancer: an illustrative case report and literature review.

Gary D Lewis1,2, Stephen B Chiang3, E Brian Butler1, Bin S Teh1.   

Abstract

The liver is a common site for metastatic disease for many cancers. Radiation therapy is one means of treatment for liver metastases, especially for patients unable to undergo surgery or ineligible for systemic chemotherapy. In particular, stereotactic body radiotherapy (SBRT) has become an important option in the treatment of metastatic disease in the liver. SBRT delivers ablative doses of radiation in relatively few fractions. As such, precise and clear imaging plays an important role in maximizing disease control while minimizing normal tissue toxicity. We present a case that highlights the importance of using multiple imaging modalities for target volume delineation in stereotactic radiation treatment of liver metastases.

Entities:  

Keywords:  PET scan; Stereotactic body radiotherapy (SBRT); gastric cancer; image-guided radiotherapy (IGRT); liver metastasis

Year:  2017        PMID: 28736648      PMCID: PMC5506288          DOI: 10.21037/jgo.2017.01.18

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  10 in total

Review 1.  Clinical evidence on PET-CT for radiation therapy planning in gastro-intestinal tumors.

Authors:  Maarten Lambrecht; Karin Haustermans
Journal:  Radiother Oncol       Date:  2010-08-18       Impact factor: 6.280

Review 2.  Radiotherapy for liver metastases: a review of evidence.

Authors:  Morten Høyer; Anand Swaminath; Sean Bydder; Michael Lock; Alejandra Méndez Romero; Brian Kavanagh; Karyn A Goodman; Paul Okunieff; Laura A Dawson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-01       Impact factor: 7.038

3.  Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.

Authors:  R A Bundschuh; N Andratschke; J Dinges; M N Duma; S T Astner; M Brügel; S I Ziegler; M Molls; M Schwaiger; M Essler
Journal:  Strahlenther Onkol       Date:  2012-03-24       Impact factor: 3.621

4.  FDG PET imaging in the staging and management of gastric cancer.

Authors:  Shane Hopkins; Gary Y Yang
Journal:  J Gastrointest Oncol       Date:  2011-03

5.  The role of ¹⁸F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?

Authors:  Ahmet Bilici; Bala Basak Oven Ustaalioglu; Mesut Seker; Umut Kefeli; Nesrin Canpolat; Bulent Tekinsoy; Sule Ozugur; Mahmut Gumus
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-14       Impact factor: 9.236

6.  Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: Initial experience.

Authors:  R E Wurm; F Gum; S Erbel; L Schlenger; D Scheffler; D Agaoglu; R Schild; B Gebauer; P Rogalla; M Plotkin; K Ocran; V Budach
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

Review 7.  Japanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.

Authors:  Hideaki Shimada; Shinichi Okazumi; Masamichi Koyama; Koji Murakami
Journal:  Gastric Cancer       Date:  2011-02-18       Impact factor: 7.370

8.  The impact of 18F-FDG PET/CT in patients with liver metastases.

Authors:  Siew C Chua; Ashley M Groves; Irfan Kayani; Leon Menezes; Svetislav Gacinovic; Yong Du; Jamshed B Bomanji; Peter J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-08-23       Impact factor: 9.236

Review 9.  FDG-PET has no definite role in preoperative imaging in gastric cancer.

Authors:  A E Dassen; D J Lips; C J Hoekstra; J F M Pruijt; K Bosscha
Journal:  Eur J Surg Oncol       Date:  2009-01-14       Impact factor: 4.424

10.  Integrating respiratory-gated PET-based target volume delineation in liver SBRT planning, a pilot study.

Authors:  Olivier Riou; Benjamin Serrano; David Azria; Benoit Paulmier; Remy Villeneuve; Pascal Fenoglietto; Antonella Artenie; Cécile Ortholan; Marc Faraggi; Juliette Thariat
Journal:  Radiat Oncol       Date:  2014-06-02       Impact factor: 3.481

  10 in total
  1 in total

Review 1.  Multimodality Treatment in Metastatic Gastric Cancer: From Past to Next Future.

Authors:  Alessandro Parisi; Giampiero Porzio; Corrado Ficorella
Journal:  Cancers (Basel)       Date:  2020-09-11       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.